APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiallergic Non-Drug Supplements

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antiallergic Non-Drug Supplements Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchAntiallergic Non-Drug Supplements Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiallergic Non-Drug Supplements Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Antiallergic Non-Drug Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiallergic Non-Drug Supplements Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiallergic Non-Drug Supplements Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Antiallergic Non-Drug Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Antiallergic Non-Drug Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antiallergic Non-Drug Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antiallergic Non-Drug Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antiallergic Non-Drug Supplements is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Antiallergic Non-Drug Supplements include Thompson's, BY-HEALTH, Costco (Kirkland Signature), General Nutrition Center, FANCL Corporation, Blackmores, Zahler, VitaTree and Healthy Care, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Antiallergic Non-Drug Supplements, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antiallergic Non-Drug Supplements, also provides the revenue of main regions and countries. Of the upcoming market potential for Antiallergic Non-Drug Supplements, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antiallergic Non-Drug Supplements revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antiallergic Non-Drug Supplements market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Antiallergic Non-Drug Supplements revenue, projected growth trends, production technology, application and end-user industry.

Antiallergic Non-Drug Supplements Segment by Company

Thompson's

BY-HEALTH

Costco (Kirkland Signature)

General Nutrition Center

FANCL Corporation

Blackmores

Zahler

VitaTree

Healthy Care

Emerald Labs

Antiallergic Non-Drug Supplements Segment by Type

Liquids

Tablets

Capsules

Antiallergic Non-Drug Supplements Segment by Application

Pollen Allergy

Dust Mites Allergy

Others

Antiallergic Non-Drug Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiallergic Non-Drug Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiallergic Non-Drug Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiallergic Non-Drug Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Antiallergic Non-Drug Supplements in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Antiallergic Non-Drug Supplements company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiallergic Non-Drug Supplements revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antiallergic Non-Drug Supplements Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liquids Major Player Table 3. Tablets Major Player Table 4. Capsules Major Player Table 5. Global Antiallergic Non-Drug Supplements Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pollen Allergy Major Player Table 7. Dust Mites Allergy Major Player Table 8. Others Major Player Table 9. Antiallergic Non-Drug Supplements Industry Trends Table 10. Antiallergic Non-Drug Supplements Industry Drivers Table 11. Antiallergic Non-Drug Supplements Industry Opportunities and Challenges Table 12. Antiallergic Non-Drug Supplements Industry Restraints Table 13. Global Antiallergic Non-Drug Supplements Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Antiallergic Non-Drug Supplements Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Antiallergic Non-Drug Supplements Market Share by Region (2021-2026) Table 16. Global Antiallergic Non-Drug Supplements Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Antiallergic Non-Drug Supplements Market Share by Region (2027-2032) Table 18. Global Antiallergic Non-Drug Supplements Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Antiallergic Non-Drug Supplements Revenue Market Share by Players (2021-2026) Table 20. Global Antiallergic Non-Drug Supplements Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Antiallergic Non-Drug Supplements Key Players Headquarters & Area Served Table 22. Global Antiallergic Non-Drug Supplements Players, Product Type & Application Table 23. Global Antiallergic Non-Drug Supplements Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Antiallergic Non-Drug Supplements by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Antiallergic Non-Drug Supplements Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Antiallergic Non-Drug Supplements Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Antiallergic Non-Drug Supplements Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Antiallergic Non-Drug Supplements Revenue Market Share by Type (2021-2026) Table 30. Global Antiallergic Non-Drug Supplements Revenue Market Share by Type (2027-2032) Table 31. Global Antiallergic Non-Drug Supplements Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Antiallergic Non-Drug Supplements Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Antiallergic Non-Drug Supplements Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Antiallergic Non-Drug Supplements Revenue Market Share by Application (2021-2026) Table 35. Global Antiallergic Non-Drug Supplements Revenue Market Share by Application (2027-2032) Table 36. Thompson's Company Information Table 37. Thompson's Business Overview Table 38. Thompson's Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Thompson's Antiallergic Non-Drug Supplements Product Portfolio Table 40. Thompson's Recent Development Table 41. BY-HEALTH Company Information Table 42. BY-HEALTH Business Overview Table 43. BY-HEALTH Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. BY-HEALTH Antiallergic Non-Drug Supplements Product Portfolio Table 45. BY-HEALTH Recent Development Table 46. Costco (Kirkland Signature) Company Information Table 47. Costco (Kirkland Signature) Business Overview Table 48. Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Product Portfolio Table 50. Costco (Kirkland Signature) Recent Development Table 51. General Nutrition Center Company Information Table 52. General Nutrition Center Business Overview Table 53. General Nutrition Center Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. General Nutrition Center Antiallergic Non-Drug Supplements Product Portfolio Table 55. General Nutrition Center Recent Development Table 56. FANCL Corporation Company Information Table 57. FANCL Corporation Business Overview Table 58. FANCL Corporation Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. FANCL Corporation Antiallergic Non-Drug Supplements Product Portfolio Table 60. FANCL Corporation Recent Development Table 61. Blackmores Company Information Table 62. Blackmores Business Overview Table 63. Blackmores Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Blackmores Antiallergic Non-Drug Supplements Product Portfolio Table 65. Blackmores Recent Development Table 66. Zahler Company Information Table 67. Zahler Business Overview Table 68. Zahler Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Zahler Antiallergic Non-Drug Supplements Product Portfolio Table 70. Zahler Recent Development Table 71. VitaTree Company Information Table 72. VitaTree Business Overview Table 73. VitaTree Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. VitaTree Antiallergic Non-Drug Supplements Product Portfolio Table 75. VitaTree Recent Development Table 76. Healthy Care Company Information Table 77. Healthy Care Business Overview Table 78. Healthy Care Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Healthy Care Antiallergic Non-Drug Supplements Product Portfolio Table 80. Healthy Care Recent Development Table 81. Emerald Labs Company Information Table 82. Emerald Labs Business Overview Table 83. Emerald Labs Antiallergic Non-Drug Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Emerald Labs Antiallergic Non-Drug Supplements Product Portfolio Table 85. Emerald Labs Recent Development Table 86. North America Antiallergic Non-Drug Supplements Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Antiallergic Non-Drug Supplements Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Antiallergic Non-Drug Supplements Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Antiallergic Non-Drug Supplements Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Antiallergic Non-Drug Supplements Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Antiallergic Non-Drug Supplements Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Antiallergic Non-Drug Supplements Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Antiallergic Non-Drug Supplements Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Antiallergic Non-Drug Supplements Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Antiallergic Non-Drug Supplements Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Antiallergic Non-Drug Supplements Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Antiallergic Non-Drug Supplements Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Antiallergic Non-Drug Supplements Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Antiallergic Non-Drug Supplements Revenue by Country (US$ Million) & (2027-2032) Table 100. China Antiallergic Non-Drug Supplements Revenue by Type (2021-2026) & (US$ Million) Table 101. China Antiallergic Non-Drug Supplements Revenue by Type (2027-2032) & (US$ Million) Table 102. China Antiallergic Non-Drug Supplements Revenue by Application (2021-2026) & (US$ Million) Table 103. China Antiallergic Non-Drug Supplements Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Antiallergic Non-Drug Supplements Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Antiallergic Non-Drug Supplements Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Antiallergic Non-Drug Supplements Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Antiallergic Non-Drug Supplements Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Antiallergic Non-Drug Supplements Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Antiallergic Non-Drug Supplements Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Antiallergic Non-Drug Supplements Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Antiallergic Non-Drug Supplements Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Antiallergic Non-Drug Supplements Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Antiallergic Non-Drug Supplements Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Antiallergic Non-Drug Supplements Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Antiallergic Non-Drug Supplements Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Antiallergic Non-Drug Supplements Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Antiallergic Non-Drug Supplements Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Antiallergic Non-Drug Supplements Image Figure 2. Global Antiallergic Non-Drug Supplements Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiallergic Non-Drug Supplements Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liquids Image Figure 5. Tablets Image Figure 6. Capsules Image Figure 7. Global Antiallergic Non-Drug Supplements Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Antiallergic Non-Drug Supplements Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pollen Allergy Image Figure 10. Dust Mites Allergy Image Figure 11. Others Image Figure 12. Global Antiallergic Non-Drug Supplements Market Size (US$ Million) & (2021-2032) Figure 13. Global Antiallergic Non-Drug Supplements Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Antiallergic Non-Drug Supplements Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Antiallergic Non-Drug Supplements Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Antiallergic Non-Drug Supplements Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Antiallergic Non-Drug Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Antiallergic Non-Drug Supplements Revenue Market Share by Type (2021-2032) Figure 20. Global Antiallergic Non-Drug Supplements Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Antiallergic Non-Drug Supplements Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Antiallergic Non-Drug Supplements Revenue Market Share by Application (2021-2032) Figure 23. North America Antiallergic Non-Drug Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032) Figure 25. North America Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032) Figure 26. North America Antiallergic Non-Drug Supplements Revenue Share by Country (2021-2032) Figure 27. United States Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Antiallergic Non-Drug Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032) Figure 32. Europe Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032) Figure 33. Europe Antiallergic Non-Drug Supplements Revenue Share by Country (2021-2032) Figure 34. Germany Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Antiallergic Non-Drug Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032) Figure 44. China Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032) Figure 45. Asia Antiallergic Non-Drug Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032) Figure 47. Asia Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032) Figure 48. Asia Antiallergic Non-Drug Supplements Revenue Share by Region (2021-2032) Figure 49. Japan Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Antiallergic Non-Drug Supplements Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032) Figure 57. SAMEA Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032) Figure 58. SAMEA Antiallergic Non-Drug Supplements Revenue Share by Country (2021-2032) Figure 59. Brazil Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Antiallergic Non-Drug Supplements Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Liquids
  • Tablets
  • Capsules
Applications
  • Pollen Allergy
  • Dust Mites Allergy
  • Others
Companies covered
  • Thompson's
  • BY-HEALTH
  • Costco (Kirkland Signature)
  • General Nutrition Center
  • FANCL Corporation
  • Blackmores
  • Zahler
  • VitaTree
  • Healthy Care
  • Emerald Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antiallergic Non-Drug Supplements Market by Type
  3. 1.2.1 Global Antiallergic Non-Drug Supplements Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liquids
  5. 1.2.3 Tablets
  6. 1.2.4 Capsules
  7. 1.3 Antiallergic Non-Drug Supplements Market by Application
  8. 1.3.1 Global Antiallergic Non-Drug Supplements Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pollen Allergy
  10. 1.3.3 Dust Mites Allergy
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Antiallergic Non-Drug Supplements Market Dynamics
  1. 2.1 Antiallergic Non-Drug Supplements Industry Trends
  2. 2.2 Antiallergic Non-Drug Supplements Industry Drivers
  3. 2.3 Antiallergic Non-Drug Supplements Industry Opportunities and Challenges
  4. 2.4 Antiallergic Non-Drug Supplements Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Antiallergic Non-Drug Supplements Market Perspective (2021-2032)
  2. 3.2 Global Antiallergic Non-Drug Supplements Growth Trends by Region
  3. 3.2.1 Global Antiallergic Non-Drug Supplements Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antiallergic Non-Drug Supplements Market Size by Region (2021-2026)
  5. 3.2.3 Global Antiallergic Non-Drug Supplements Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Antiallergic Non-Drug Supplements Revenue by Players
  2. 4.1.1 Global Antiallergic Non-Drug Supplements Revenue by Players (2021-2026)
  3. 4.1.2 Global Antiallergic Non-Drug Supplements Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Antiallergic Non-Drug Supplements Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antiallergic Non-Drug Supplements Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Antiallergic Non-Drug Supplements Key Players Headquarters & Area Served
  7. 4.4 Global Antiallergic Non-Drug Supplements Players, Product Type & Application
  8. 4.5 Global Antiallergic Non-Drug Supplements Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Antiallergic Non-Drug Supplements Market CR5 and HHI
  11. 4.6.3 2025 Antiallergic Non-Drug Supplements Tier 1, Tier 2, and Tier 3
5 Antiallergic Non-Drug Supplements Market Size by Type
  1. 5.1 Global Antiallergic Non-Drug Supplements Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Antiallergic Non-Drug Supplements Revenue by Type (2021-2032)
  3. 5.3 Global Antiallergic Non-Drug Supplements Revenue Market Share by Type (2021-2032)
6 Antiallergic Non-Drug Supplements Market Size by Application
  1. 6.1 Global Antiallergic Non-Drug Supplements Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Antiallergic Non-Drug Supplements Revenue by Application (2021-2032)
  3. 6.3 Global Antiallergic Non-Drug Supplements Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thompson's
  2. 7.1.1 Thompson's Company Information
  3. 7.1.2 Thompson's Business Overview
  4. 7.1.3 Thompson's Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thompson's Antiallergic Non-Drug Supplements Product Portfolio
  6. 7.1.5 Thompson's Recent Developments
  7. 7.2 BY-HEALTH
  8. 7.2.1 BY-HEALTH Company Information
  9. 7.2.2 BY-HEALTH Business Overview
  10. 7.2.3 BY-HEALTH Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BY-HEALTH Antiallergic Non-Drug Supplements Product Portfolio
  12. 7.2.5 BY-HEALTH Recent Developments
  13. 7.3 Costco (Kirkland Signature)
  14. 7.3.1 Costco (Kirkland Signature) Company Information
  15. 7.3.2 Costco (Kirkland Signature) Business Overview
  16. 7.3.3 Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Costco (Kirkland Signature) Antiallergic Non-Drug Supplements Product Portfolio
  18. 7.3.5 Costco (Kirkland Signature) Recent Developments
  19. 7.4 General Nutrition Center
  20. 7.4.1 General Nutrition Center Company Information
  21. 7.4.2 General Nutrition Center Business Overview
  22. 7.4.3 General Nutrition Center Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  23. 7.4.4 General Nutrition Center Antiallergic Non-Drug Supplements Product Portfolio
  24. 7.4.5 General Nutrition Center Recent Developments
  25. 7.5 FANCL Corporation
  26. 7.5.1 FANCL Corporation Company Information
  27. 7.5.2 FANCL Corporation Business Overview
  28. 7.5.3 FANCL Corporation Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  29. 7.5.4 FANCL Corporation Antiallergic Non-Drug Supplements Product Portfolio
  30. 7.5.5 FANCL Corporation Recent Developments
  31. 7.6 Blackmores
  32. 7.6.1 Blackmores Company Information
  33. 7.6.2 Blackmores Business Overview
  34. 7.6.3 Blackmores Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Blackmores Antiallergic Non-Drug Supplements Product Portfolio
  36. 7.6.5 Blackmores Recent Developments
  37. 7.7 Zahler
  38. 7.7.1 Zahler Company Information
  39. 7.7.2 Zahler Business Overview
  40. 7.7.3 Zahler Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Zahler Antiallergic Non-Drug Supplements Product Portfolio
  42. 7.7.5 Zahler Recent Developments
  43. 7.8 VitaTree
  44. 7.8.1 VitaTree Company Information
  45. 7.8.2 VitaTree Business Overview
  46. 7.8.3 VitaTree Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  47. 7.8.4 VitaTree Antiallergic Non-Drug Supplements Product Portfolio
  48. 7.8.5 VitaTree Recent Developments
  49. 7.9 Healthy Care
  50. 7.9.1 Healthy Care Company Information
  51. 7.9.2 Healthy Care Business Overview
  52. 7.9.3 Healthy Care Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Healthy Care Antiallergic Non-Drug Supplements Product Portfolio
  54. 7.9.5 Healthy Care Recent Developments
  55. 7.10 Emerald Labs
  56. 7.10.1 Emerald Labs Company Information
  57. 7.10.2 Emerald Labs Business Overview
  58. 7.10.3 Emerald Labs Antiallergic Non-Drug Supplements Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Emerald Labs Antiallergic Non-Drug Supplements Product Portfolio
  60. 7.10.5 Emerald Labs Recent Developments
8 North America
  1. 8.1 North America Antiallergic Non-Drug Supplements Revenue (2021-2032)
  2. 8.2 North America Antiallergic Non-Drug Supplements Revenue by Type (2021-2032)
  3. 8.2.1 North America Antiallergic Non-Drug Supplements Revenue by Type (2021-2026)
  4. 8.2.2 North America Antiallergic Non-Drug Supplements Revenue by Type (2027-2032)
  5. 8.3 North America Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032)
  6. 8.4 North America Antiallergic Non-Drug Supplements Revenue by Application (2021-2032)
  7. 8.4.1 North America Antiallergic Non-Drug Supplements Revenue by Application (2021-2026)
  8. 8.4.2 North America Antiallergic Non-Drug Supplements Revenue by Application (2027-2032)
  9. 8.5 North America Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032)
  10. 8.6 North America Antiallergic Non-Drug Supplements Revenue by Country
  11. 8.6.1 North America Antiallergic Non-Drug Supplements Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Antiallergic Non-Drug Supplements Revenue by Country (2021-2026)
  13. 8.6.3 North America Antiallergic Non-Drug Supplements Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Antiallergic Non-Drug Supplements Revenue (2021-2032)
  2. 9.2 Europe Antiallergic Non-Drug Supplements Revenue by Type (2021-2032)
  3. 9.2.1 Europe Antiallergic Non-Drug Supplements Revenue by Type (2021-2026)
  4. 9.2.2 Europe Antiallergic Non-Drug Supplements Revenue by Type (2027-2032)
  5. 9.3 Europe Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032)
  6. 9.4 Europe Antiallergic Non-Drug Supplements Revenue by Application (2021-2032)
  7. 9.4.1 Europe Antiallergic Non-Drug Supplements Revenue by Application (2021-2026)
  8. 9.4.2 Europe Antiallergic Non-Drug Supplements Revenue by Application (2027-2032)
  9. 9.5 Europe Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032)
  10. 9.6 Europe Antiallergic Non-Drug Supplements Revenue by Country
  11. 9.6.1 Europe Antiallergic Non-Drug Supplements Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Antiallergic Non-Drug Supplements Revenue by Country (2021-2026)
  13. 9.6.3 Europe Antiallergic Non-Drug Supplements Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Antiallergic Non-Drug Supplements Revenue (2021-2032)
  2. 10.2 China Antiallergic Non-Drug Supplements Revenue by Type (2021-2032)
  3. 10.2.1 China Antiallergic Non-Drug Supplements Revenue by Type (2021-2026)
  4. 10.2.2 China Antiallergic Non-Drug Supplements Revenue by Type (2027-2032)
  5. 10.3 China Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032)
  6. 10.4 China Antiallergic Non-Drug Supplements Revenue by Application (2021-2032)
  7. 10.4.1 China Antiallergic Non-Drug Supplements Revenue by Application (2021-2026)
  8. 10.4.2 China Antiallergic Non-Drug Supplements Revenue by Application (2027-2032)
  9. 10.5 China Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antiallergic Non-Drug Supplements Revenue (2021-2032)
  2. 11.2 Asia Antiallergic Non-Drug Supplements Revenue by Type (2021-2032)
  3. 11.2.1 Asia Antiallergic Non-Drug Supplements Revenue by Type (2021-2026)
  4. 11.2.2 Asia Antiallergic Non-Drug Supplements Revenue by Type (2027-2032)
  5. 11.3 Asia Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032)
  6. 11.4 Asia Antiallergic Non-Drug Supplements Revenue by Application (2021-2032)
  7. 11.4.1 Asia Antiallergic Non-Drug Supplements Revenue by Application (2021-2026)
  8. 11.4.2 Asia Antiallergic Non-Drug Supplements Revenue by Application (2027-2032)
  9. 11.5 Asia Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032)
  10. 11.6 Asia Antiallergic Non-Drug Supplements Revenue by Country
  11. 11.6.1 Asia Antiallergic Non-Drug Supplements Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Antiallergic Non-Drug Supplements Revenue by Country (2021-2026)
  13. 11.6.3 Asia Antiallergic Non-Drug Supplements Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antiallergic Non-Drug Supplements Revenue (2021-2032)
  2. 12.2 SAMEA Antiallergic Non-Drug Supplements Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Antiallergic Non-Drug Supplements Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Antiallergic Non-Drug Supplements Revenue by Type (2027-2032)
  5. 12.3 SAMEA Antiallergic Non-Drug Supplements Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Antiallergic Non-Drug Supplements Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Antiallergic Non-Drug Supplements Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Antiallergic Non-Drug Supplements Revenue by Application (2027-2032)
  9. 12.5 SAMEA Antiallergic Non-Drug Supplements Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Antiallergic Non-Drug Supplements Revenue by Country
  11. 12.6.1 SAMEA Antiallergic Non-Drug Supplements Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Antiallergic Non-Drug Supplements Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Antiallergic Non-Drug Supplements Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst